The University of Utah names Gina R. Hawley, Dr.P.H., M.H.A., chief operating officer for University of Utah Health Hospitals and Clinics.

A Becker's Hospital Review article highlighting health systems' initiatives to help people experiencing homelessness mentions the expansion of OHSU's Ashland-based Street Nursing Program.

New research led by Marcel Curlin, M.D., and Fikadu Tafasse, Ph.D., suggests vaccine boosters and breakthrough infections following vaccination both provide a substantial and potentially pandemic-breaking immunity against COVID-19.

The OHSU Knight Cancer Institute is included in a Newsweek list of the world’s top specialized hospitals for oncology.

The annual Pink Ball Golf Tournament raises $74,000 for OHSU cancer research.

OHSU and AFSCME reach tentative agreement.

Todd Korthuis, M.D., warns a senate interim committee that drug addiction in the state of Oregon is worsening: “Fentanyl and methamphetamine, which is often contaminated with fentanyl, are now the most common illegal drugs that people use in Oregon. This is leading to a health crisis that is worsening before our eyes”

Fennec Pharmaceuticals announces the FDA approval of PEDMARK to reduce the risk of ototoxicity associated with cisplatin in pediatric patients age 1 month and older with localized, non-metastatic solid tumors. The company's CEO says: "We would like to thank the patients, their families, physicians, investigators, employees, consultants and the entire research team at Oregon Health & Science University, who have contributed to the development of PEDMARK"

In a Newsweek article on the efficacy of antidepressant medication, Erick Turner, M.D., says the failure rate of antidepressant clinical trials is far higher than most people understand.

The American Association for Cancer Research publishes its latest cancer progress report highlighting how basic, translational and clinical cancer research remain vitally important to improving health and saving lives. AACR President Lisa Coussens, Ph.D., says: "You can’t stop funding basic science now with the belief that the current treatments will be good enough. Investing in basic science has a huge payoff to the public.”